TEV-48125

Lilly and Teva tout new migraine data amid a crowded race
Fierce Biotech
Fri, 06/19/15 - 10:55 am
Eli Lilly
Teva Pharmaceutical
migraines
LY2951742
TEV-48125
Teva’s TEV-48125 Meets Primary and Secondary Endpoints in Episodic Migraine Study, Demonstrating Treatment Concept After a Single Dose
Yahoo
Tue, 03/24/15 - 08:49 am
Teva Pharmaceutical
TEV-48125
migraines
episodic migraines
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Releases Positive Results for Phase IIb Study
Streetwise Report
Wed, 02/25/15 - 10:16 am
Teva Pharmaceuticals
TEV-48125
migraine